LP 130
| Code | Size | Price |
|---|
| TAR-T24416-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
LP 130 is an inhibitor of retroviral protease.
CAS:
153314-49-9
Formula:
C46H58N6O9
Molecular Weight:
839.003
Purity:
0.98
SMILES:
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(C)=O)C(C)C)[C@@H](O)CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(N)=O
References
1. Huang HF, Huo XM, Huo LJ, Shen FJ, Wu LL. [Effect of valsartan on the expression of leptin, leptin receptor and collagen in rats with hepatic fibrosis]. Zhonghua Gan Zang Bing Za Zhi. 2018 Feb 20;26(2):119-124. doi: 10.3760/cma.j.issn.1007-3418.2018.02.009. Chinese. PubMed PMID: 29804378.
2. Ray KK, Stoekenbroek RM, Kallend D, Leiter LA, Landmesser U, Wright RS, Wijngaard P, Kastelein JJ. Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Pre-Specified Secondary End Points in ORION 1. Circulation. 2018 May 7. pii: CIRCULATIONAHA.118.034710. doi: 10.1161/CIRCULATIONAHA.118.034710. [Epub ahead of print] PubMed PMID: 29735484.
3. Uzna?ska-Loch B, Wik?o K, Trzos E, Wierzbowska-Drabik K, Chrzanowski ?, Kasprzak JD, Kurpesa M. Advanced and traditional electrocardiographic risk factors in pulmonary arterial hypertension: the significance of ventricular late potentials. Kardiol Pol. 2018;76(3):586-593. doi: 10.5603/KP.a2017.0257. Epub 2018 Jan 3. PubMed PMID: 29297193.
4. Czubkowski P, Wierzbicka A, Paw?owska J, Jankowska I, Socha P. Obesity, lipid profiles and oxidative stress in children after liver transplantation. Acta Biochim Pol. 2017;64(4):661-665. doi: 10.18388/abp.2017_1623. Epub 2017 Dec 10. PubMed PMID: 29222858.